EntrepreneurialCheck
Jason Kerkvliet estimated net worth profile

Jason Kerkvliet net worth

Jason Kerkvliet Net Worth 2026 (Estimated) · Founder at LifestyleRx · YC S23
est. wealth $5.0M

Quick answer

Jason Kerkvliet's estimated net worth is $5.0M (range $3.5M – $7.5M) as of 2026. Jason Kerkvliet is Founder at LifestyleRx. LifestyleRx valuation.

Jason Kerkvliet is Founder at LifestyleRx (YC S23). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameJason Kerkvliet
RoleFounder
CompanyLifestyleRx
YC batchS23
Est. company val$20.0M
Assumed ownership25%
Est. paper wealth / net worth$5.0M
$3.5M – $7.5M
  • Company status: Active
  • Education: Stanford University
  • Region: United States of America
  • Industries: Healthcare, Healthcare Services
  • Team size: 9
  • Website: https://lifestylerx.io/

Who is Jason Kerkvliet?

Jason Kerkvliet is a founder at LifestyleRx, a startup participating in Y Combinator's Summer 2023 batch.

Highlights:

  • Stanford University
  • Y Combinator
  • LifestyleRx

About LifestyleRx

LifestyleRx delivers insurance-covered virtual care for Type 2 Diabetes reversal. Our doctors guide patients through lifestyle changes to reverse the underlying process of diabetes.

FAQ: Jason Kerkvliet net worth and LifestyleRx valuation

What is Jason Kerkvliet's net worth?

Jason Kerkvliet's estimated net worth is $5.0M (range $3.5M – $7.5M) as of 2026. Jason Kerkvliet is Founder at LifestyleRx. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is LifestyleRx valuation?

LifestyleRx's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Jason Kerkvliet's role?

Jason Kerkvliet is Founder at LifestyleRx, a Y Combinator-backed startup (batch S23).